The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Guidelines of care for the management of primary cutaneous melanoma
Abstract
The incidence of primary cutaneous melanoma continues to increase each year. Melanoma accounts for the majority of skin cancer-related deaths, but treatment is usually curative following early detection of disease. In this American Academy of Dermatology clinical practice guideline, updated treatment recommendations are provided for patients with primary cutaneous melanoma (American Joint Committee on Cancer stages 0-IIC and pathologic stage III by virtue of a positive sentinel lymph node biopsy). Biopsy techniques for a lesion that is clinically suggestive of melanoma are reviewed, as are recommendations for the histopathologic interpretation of cutaneous melanoma. The use of laboratory, molecular, and imaging tests is examined in the initial work-up of patients with newly diagnosed melanoma and for follow-up of asymptomatic patients. With regard to treatment of primary cutaneous melanoma, recommendations for surgical margins and the concepts of staged excision (including Mohs micrographic surgery) and nonsurgical treatments for melanoma in situ, lentigo maligna type (including topical imiquimod and radiation therapy), are updated. The role of sentinel lymph node biopsy as a staging technique for cutaneous melanoma is described, with recommendations for its use in clinical practice. Finally, current data regarding pregnancy and melanoma, genetic testing for familial melanoma, and management of dermatologic toxicities related to novel targeted agents and immunotherapies for patients with advanced disease are summarized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362
Self-citationSafety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,602
Self-citationSafety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W.-J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305133 · Cited by 3,392
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Andtbacka, R. H. I., Kaufman, H. L., Collichio, F., Amatruda, T., Senzer, N., Chesney, J., Delman, K. A., Spitler, L. E., Puzanov, I., Agarwala, S. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3377 · Cited by 2,634
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
Self-citationGershenwald, J. E., Scolyer, R. A., Hess, K. R., Sondak, V. K., Long, G. V., Ross, M. I., Lazar, A. J., Faries, M. B., Kirkwood, J. M., McArthur, G. A., et al. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21409 · Cited by 2,283
Self-citationAdjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma
Weber, J., Mandala, M., Del Vecchio, M., Gogas, H. J., Arance, A. M., Cowey, C. L., Dalle, S., Schenker, M., Chiarion-Sileni, V., Marquez-Rodas, I., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709030 · Cited by 2,246
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Flaherty, K. T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M., Demidov, L. V., Hassel, J. C., Rutkowski, P., Mohr, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203421 · Cited by 2,160
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
Long, G. V., Hauschild, A., Santinami, M., Atkinson, V., Mandalà, M., Chiarion-Sileni, V., Larkin, J., Nyakas, M., Dutriaux, C., Haydon, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708539 · Cited by 1,490
Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., Karakousis, C. P., Puleo, C. A., Coventry, B. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310460 · Cited by 1,484
Self-citationCompletion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Faries, M. B., Thompson, J. F., Cochran, A. J., Andtbacka, R. H., Mozzillo, N., Zager, J. S., Jahkola, T., Bowles, T. L., Testori, A., Beitsch, P. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613210 · Cited by 1,414
Self-citationProlonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
Eggermont, A. M. M., Chiarion-Sileni, V., Grob, J.-J., Dummer, R., Wolchok, J. D., Schmidt, H., Hamid, O., Robert, C., Ascierto, P. A., Richards, J. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611299 · Cited by 1,318
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
Clark, W. H., Elder, D. E., Guerry, D., Braitman, L. E., Trock, B. J., Schultz, D., Synnestvedt, M., & Halpern, A. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1893 · Cited by 1,247
Self-citationClemente, C. G., Mihm, M. C., Bufalino, R., Zurrida, S., Collini, P., & Cascinelli, N. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1303::aid-cncr12>3.0.co;2-5 · Cited by 1,171
Horvat, T. Z., Adel, N. G., Dang, T.-O., Momtaz, P., Postow, M. A., Callahan, M. K., Carvajal, R. D., Dickson, M. A., D'Angelo, S. P., Woo, K. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.8448 · Cited by 1,064
Menzies, A. M., Johnson, D. B., Ramanujam, S., Atkinson, V. G., Wong, A. N. M., Park, J. J., McQuade, J. L., Shoushtari, A. N., Tsai, K. K., Eroglu, Z., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw443 · Cited by 817
Morton, D. L., Cochran, A. J., Thompson, J. F., Elashoff, R., Essner, R., Glass, E. C., Mozzillo, N., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000181092.50141.fa · Cited by 715
Self-citationCutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dummer, R., Hauschild, A., Guggenheim, M., Keilholz, U., & Pentheroudakis, G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds229 · Cited by 714
Leiter, U., Stadler, R., Mauch, C., Hohenberger, W., Brockmeyer, N., Berking, C., Sunderkötter, C., Kaatz, M., Schulte, K.-W., Lehmann, P., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00141-8 · Cited by 707
Hua, C., Boussemart, L., Mateus, C., Routier, E., Boutros, C., Cazenave, H., Viollet, R., Thomas, M., Roy, S., Benannoune, N., et al. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.2707 · Cited by 655
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
Hofmann, L., Forschner, A., Loquai, C., Goldinger, S. M., Zimmer, L., Ugurel, S., Schmidgen, M. I., Gutzmer, R., Utikal, J. S., Göppner, D., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.02.025 · Cited by 649
Teulings, H.-E., Limpens, J., Jansen, S. N., Zwinderman, A. H., Reitsma, J. B., Spuls, P. I., & Luiten, R. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.4756 · Cited by 625
Guidelines of care for the management of primary cutaneous melanoma
Bichakjian, C. K., Halpern, A. C., Johnson, T. M., Foote Hood, A., Grichnik, J. M., Swetter, S. M., Tsao, H., Barbosa, V. H., Chuang, T.-Y., Duvic, M., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.031 · Cited by 616
Self-citationThin Stage I Primary Cutaneous Malignant Melanoma
Veronesi, U., Cascinelli, N., Adamus, J., Balch, C., Bandiera, D., Barchuk, A., Bufalino, R., Craig, P., De Marsillac, J., Durand, J. C., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181804 · Cited by 563
Ebell, M. H., Siwek, J., Weiss, B. D., Woolf, S. H., Susman, J., Ewigman, B., & Bowman, M. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.1.59 · Cited by 561
Balch, C. M., Urist, M. M., Karakousis, C. P., Smith, T. J., Temple, W. J., Drzewiecki, K., Jewell, W. R., Bartolucci, A. A., Mihm, M. C., Barnhill, R., et al. (1993) · Annals of Surgery · doi:10.1097/00000658-199309000-00005 · Cited by 525
Excision Margins in High-Risk Malignant Melanoma
Thomas, J. M., Newton‐Bishop, J., A’Hern, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030681 · Cited by 504
Narrow Excision (1-cm Margin): A Safe Procedure for Thin Cutaneous Melanoma
Veronesi, U. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410280036004 · Cited by 495
Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
Winnepenninckx, V., Lazar, V., Michiels, S., Dessen, P., Stas, M., Alonso, S. R., Avril, M.-F., Ortiz Romero, P. L., Robert, T., Balacescu, O., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj103 · Cited by 480
Kim, K. B., Kefford, R., Pavlick, A. C., Infante, J. R., Ribas, A., Sosman, J. A., Fecher, L. A., Millward, M., McArthur, G. A., Hwu, P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.5966 · Cited by 477
Abdel-Wahab, N., Shah, M., & Suarez-Almazor, M. E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160221 · Cited by 444
Elmore, J. G., Barnhill, R. L., Elder, D. E., Longton, G. M., Pepe, M. S., Reisch, L. M., Carney, P. A., Titus, L. J., Nelson, H. D., Onega, T., et al. (2017) · BMJ · doi:10.1136/bmj.j2813 · Cited by 436
Self-citationMarsden, J. R., Newton-Bishop, J. A., Burrows, L., Cook, M., Corrie, P. G., Cox, N. H., Gore, M. E., Lorigan, P., MacKie, R., Nathan, P., et al. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09883.x · Cited by 396
Thompson, J. F., Soong, S.-J., Balch, C. M., Gershenwald, J. E., Ding, S., Coit, D. G., Flaherty, K. T., Gimotty, P. A., Johnson, T., Johnson, M. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5812 · Cited by 363
Self-citationThe prognostic significance of ulceration of cutaneous melanoma
Balch, C. M., Wilkerson, J. A., Murad, T. M., Soong, S.-J., Ingalls, A. L., & Maddox, W. A. (1980) · Cancer · doi:10.1002/1097-0142(19800615)45:12<3012::aid-cncr2820451223>3.0.co;2-o · Cited by 361
Xing, Y., Bronstein, Y., Ross, M. I., Askew, R. L., Lee, J. E., Gershenwald, J. E., Royal, R., & Cormier, J. N. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq455 · Cited by 352
Self-citationSondak, V. K., Taylor, J. M. G., Sabel, M. S., Wang, Y., Lowe, L., Grover, A. C., Chang, A. E., Yahanda, A. M., Moon, J., & Johnson, T. M. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.03.044 · Cited by 328
Self-citationBAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Carbone, M., Ferris, L. K., Baumann, F., Napolitano, A., Lum, C. A., Flores, E. G., Gaudino, G., Powers, A., Bryant-Greenwood, P., Krausz, T., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-179 · Cited by 323
Predicting five-year outcome for patients with cutaneous melanoma in a population-based study
Barnhill, R. L., Fine, J. A., Roush, G. C., & Berwick, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960801)78:3<427::aid-cncr8>3.0.co;2-g · Cited by 296
Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017
Ugurel, S., Röhmel, J., Ascierto, P. A., Flaherty, K. T., Grob, J. J., Hauschild, A., Larkin, J., Long, G. V., Lorigan, P., McArthur, G. A., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.06.028 · Cited by 287
Gerami, P., Cook, R. W., Wilkinson, J., Russell, M. C., Dhillon, N., Amaria, R. N., Gonzalez, R., Lyle, S., Johnson, C. E., Oelschlager, K. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3316 · Cited by 278
Tumours associated with BAP1 mutations
Murali, R., Wiesner, T., & Scolyer, R. A. (2013) · Pathology · doi:10.1097/pat.0b013e32835d0efb · Cited by 270
Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies
Sibaud, V., Meyer, N., Lamant, L., Vigarios, E., Mazieres, J., & Delord, J. P. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000290 · Cited by 265
Romano, E., Scordo, M., Dusza, S. W., Coit, D. G., & Chapman, P. B. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.2063 · Cited by 256
Njauw, C.-N. J., Kim, I., Piris, A., Gabree, M., Taylor, M., Lane, A. M., DeAngelis, M. M., Gragoudas, E., Duncan, L. M., & Tsao, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035295 · Cited by 254
Self-citationKarakousis, C. P., Balch, C. M., Urist, M. M., Ross, M. M., Smith, T. J., & Bartolucci, A. A. (1996) · Annals of Surgical Oncology · doi:10.1007/bf02305762 · Cited by 239
Cutaneous adverse effects of targeted therapies
Macdonald, J. B., Macdonald, B., Golitz, L. E., LoRusso, P., & Sekulic, A. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.07.032 · Cited by 237
Clinicopathological Features of and Risk Factors for Multiple Primary Melanomas
Ferrone, C. R. (2005) · JAMA · doi:10.1001/jama.294.13.1647 · Cited by 233
Read, J., Wadt, K. A. W., & Hayward, N. K. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103150 · Cited by 231
Garbe, C., Peris, K., Hauschild, A., Saiag, P., Middleton, M., Spatz, A., Grob, J.-J., Malvehy, J., Newton-Bishop, J., Stratigos, A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.06.013 · Cited by 229
Gillgren, P., Drzewiecki, K. T., Niin, M., Gullestad, H. P., Hellborg, H., Månsson-Brahme, E., Ingvar, C., & Ringborg, U. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61546-8 · Cited by 228
Cutaneous head and neck melanoma treated with Mohs micrographic surgery
Bricca, G. M., Brodland, D. G., Ren, D., & Zitelli, J. A. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.08.038 · Cited by 216
Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
Segura, M. F., Belitskaya-Lévy, I., Rose, A. E., Zakrzewski, J., Gaziel, A., Hanniford, D., Darvishian, F., Berman, R. S., Shapiro, R. L., Pavlick, A. C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2721 · Cited by 215
Malvehy, J., Hauschild, A., Curiel‐Lewandrowski, C., Mohr, P., Hofmann‐Wellenhof, R., Motley, R., Berking, C., Grossman, D., Paoli, J., Loquai, C., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13121 · Cited by 210
Self-citationLymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Melanoma: A Meta-Analysis
Valsecchi, M. E., Silbermins, D., de Rosa, N., Wong, S. L., & Lyman, G. H. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.1884 · Cited by 209
Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas
Gimotty, P. A., Elder, D. E., Fraker, D. L., Botbyl, J., Sellers, K., Elenitsas, R., Ming, M. E., Schuchter, L., Spitz, F. R., Czerniecki, B. J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1463 · Cited by 208
Self-citationNext-generation sequencing: advances and applications in cancer diagnosis
Serratì, S., De Summa, S., Pilato, B., Petriella, D., Lacalamita, R., Tommasi, S., & Pinto, R. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s99807 · Cited by 208
Selection criteria for genetic assessment of patients with familial melanoma
Leachman, S. A., Carucci, J., Kohlmann, W., Banks, K. C., Asgari, M. M., Bergman, W., Bianchi-Scarrà, G., Brentnall, T., Bressac-de Paillerets, B., Bruno, W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.016 · Cited by 198
Self-citationPellacani, G., Pepe, P., Casari, A., & Longo, C. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13148 · Cited by 197
Francken, A. B., Shaw, H. M., Thompson, J. F., Soong, S.-J., Accortt, N. A., Azzola, M. F., Scolyer, R. A., Milton, G. W., McCarthy, W. H., Colman, M. H., et al. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.07.014 · Cited by 196
Self-citationHistology of sun-damaged human skin
Montagna, W., Kirchner, S., & Carlisle, K. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)70276-0 · Cited by 192
Malignant melanoma in pregnancy: A population‐based evaluation
O'Meara, A. T., Cress, R., Xing, G., Danielsen, B., & Smith, L. H. (2005) · Cancer · doi:10.1002/cncr.20925 · Cited by 189
Ipilimumab in patients with cancer and the management of dermatologic adverse events
Lacouture, M. E., Wolchok, J. D., Yosipovitch, G., Kähler, K. C., Busam, K. J., & Hauschild, A. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.02.035 · Cited by 187
Rajpara, S. M., Botello, A. P., Townend, J., & Ormerod, A. D. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09093.x · Cited by 185
Balch, C. M., Thompson, J. F., Gershenwald, J. E., Soong, S.-J., Ding, S., McMasters, K. M., Coit, D. G., Eggermont, A. M. M., Gimotty, P. A., Johnson, T. M., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3464-x · Cited by 183
Self-citationEffect of Pregnancy on Survival in Women With Cutaneous Malignant Melanoma
Lens, M. B., Rosdahl, I., Ahlbom, A., Farahmand, B. Y., Synnerstad, I., Boeryd, B., & Newton Bishop, J. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.096 · Cited by 180
Cutaneous adverse effects of targeted therapies
Macdonald, J. B., Macdonald, B., Golitz, L. E., LoRusso, P., & Sekulic, A. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.07.033 · Cited by 177
Lee, S., Barnhill, R. L., Dummer, R., Dalton, J., Wu, J., Pappo, A., & Bahrami, A. (2015) · Scientific Reports · doi:10.1038/srep11200 · Cited by 176
Gerami, P., Cook, R. W., Russell, M. C., Wilkinson, J., Amaria, R. N., Gonzalez, R., Lyle, S., Jackson, G. L., Greisinger, A. J., Johnson, C. E., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.01.009 · Cited by 167
Ultraviolet A and Photosensitivity during Vemurafenib Therapy
Dummer, R., Rinderknecht, J., & Goldinger, S. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1113752 · Cited by 166
Guerry, D., Synnestvedt, M., Elder, D. E., & Schultz, D. (1993) · Journal of Investigative Dermatology · doi:10.1038/jid.1993.60 · Cited by 165
Self-citationCarlos, G., Anforth, R., Clements, A., Menzies, A. M., Carlino, M. S., Chou, S., & Fernandez-Peñas, P. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.1745 · Cited by 162
Clarke, L. E., Warf, M. B., Flake, D. D., Hartman, A., Tahan, S. R., Shea, C. R., Gerami, P., Messina, J. L., Florell, S. R., WENSTRUP, R. J., et al. (2015) · Journal of Cutaneous Pathology · doi:10.1111/cup.12475 · Cited by 159
Hofmann, U., Szedlak, M., Rittgen, W., Jung, E. G., & Schadendorf, D. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600428 · Cited by 159
Ng, J. C., Swain, S., Dowling, J. P., Wolfe, R., Simpson, P., & Kelly, J. W. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.14 · Cited by 158
Etzkorn, J. R., Sobanko, J. F., Elenitsas, R., Newman, J. G., Goldbach, H. S., Shin, T. M., & Miller, C. J. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.01.007 · Cited by 154
Minkis, K., Garden, B. C., Wu, S., Pulitzer, M. P., & Lacouture, M. E. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.12.963 · Cited by 152
Hayes, A. J., Maynard, L., Coombes, G., Newton‐Bishop, J., Timmons, M. J., Cook, M. G., Theaker, J. M., Bliss, J. M., & Thomas, J. M. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00482-9 · Cited by 151
Role of PET in the Initial Staging of Cutaneous Malignant Melanoma: Systematic Review
Krug, B., Crott, R., Lonneux, M., Baurain, J., Pirson, A., & Borght, T. V. (2008) · Radiology · doi:10.1148/radiol.2493080240 · Cited by 149
Desmoplastic Melanoma: A Pathologically and Clinically Distinct Form of Cutaneous Melanoma
Hawkins, W. G., BUSAM, K. J., Ben‐Porat, L., Panageas, K. S., Coit, D. G., Gyorki, D. E., Linehan, D. C., & Brady, M. S. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.03.022 · Cited by 147
Cancer during pregnancy and the postpartum period: A population‐based study
Andersson, T., Johansson, A. L. V., Fredriksson, I., & Lambe, M. P. (2015) · Cancer · doi:10.1002/cncr.29325 · Cited by 143
Nagore, E., Oliver, V., Estrada, R. B., Moreno-Picot, S., Insa, A., & Fortea, J. M. (2005) · Melanoma Research · doi:10.1097/00008390-200506000-00005 · Cited by 143
Goggins, W. B., & Tsao, H. (2003) · Cancer · doi:10.1002/cncr.11116 · Cited by 140
Self-citationLeiter, U., Buettner, P. G., Eigentler, T., & Garbe, C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.074 · Cited by 127
Prediction of Survival in Patients With Thin Melanoma: Results From a Multi-Institution Study
Maurichi, A., Miceli, R., Camerini, T., Mariani, L., Patuzzo, R., Ruggeri, R., Gallino, G., Tolomio, E., Tragni, G., Valeri, B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.2340 · Cited by 127
Scolyer, R. A., Judge, M. J., Evans, A. T., Frishberg, D. P., Prieto, V. G., Thompson, J. F., Trotter, M. J., WALSH, M. Y., Walsh, N. M. G., & Ellis, D. W. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31829d7f35 · Cited by 126
Self-citationHormonal and reproductive factors in relation to melanoma in women: Current review and meta-analysis
Gandini, S., Iodice, S., Koomen, E. R., di Pietro, A., Sera, F., & Caini, S. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.023 · Cited by 125
Melanoma In Situ Versus Melanocytic Hyperplasia in Sun-damaged Skin
Weyers, W., Bonczkowitz, M., Weyers, I., Bittinger, A., & Schill, W. (1996) · American Journal of Dermatopathology · doi:10.1097/00000372-199612000-00002 · Cited by 121
Biopsy of the pigmented lesion—When and how
Tran, K. T., Wright, N. A., & Cockerell, C. J. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.05.027 · Cited by 120
Does biopsy type influence survival in clinical Stage I cutaneous melanoma?
Lederman, J. S., & Sober, A. J. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70249-6 · Cited by 119
Self-citationAge-Related Lymphatic Dysfunction in Melanoma Patients
Conway, W. C., Faries, M. B., Nicholl, M. B., Terando, A. M., Glass, E. C., Sim, M., & Morton, D. L. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0420-x · Cited by 117
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma
Kruper, L. L., Spitz, F. R., Czerniecki, B. J., Fraker, D. L., Blackwood‐Chirchir, A., Ming, M. E., Elder, D. E., Elenitsas, R., Guerry, D., & Gimotty, P. A. (2006) · Cancer · doi:10.1002/cncr.22295 · Cited by 115
Self-citationValentín‐Nogueras, S. M., Brodland, D. G., Zitelli, J. A., González‐Sepúlveda, L., & Nazario, C. M. (2016) · Dermatologic Surgery · doi:10.1097/dss.0000000000000725 · Cited by 115
The prognostic value of serum S100B in patients with cutaneous melanoma: A meta‐analysis
D, S. M. M., Zavagno, G., & Nitti, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23794 · Cited by 114
Berwick, M., Orlow, I., Hummer, A., Armstrong, B. K., Kricker, A., Marrett, L. D., Millikan, R. C., Gruber, S. B., Anton‐Culver, H., Zanetti, R., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0270 · Cited by 114
Gannon, C. J., Rousseau, D. L., Ross, M. I., Johnson, M. M., Lee, J. E., Mansfield, P. F., Cormier, J. N., Prieto, V. G., & Gershenwald, J. E. (2006) · Cancer · doi:10.1002/cncr.22320 · Cited by 111
Self-citationRegression in primary cutaneous melanoma: etiopathogenesis and clinical significance
Aung, P. P., Nagarajan, P., & Prieto, V. G. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.8 · Cited by 110
Ghiasvand, R., Rueegg, C. S., Weiderpass, E., Green, A. C., Lund, E., & Veierød, M. B. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kww148 · Cited by 108
Pruritus in patients treated with targeted cancer therapies: Systematic review and meta-analysis
Ensslin, C. J., Rosen, A. C., Wu, S., & Lacouture, M. E. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.06.038 · Cited by 106
Efficacy of Skin Self-Examination Practices for Early Melanoma Detection
Pollitt, R. A., Geller, A. C., Brooks, D. R., Johnson, T. M., Park, E. R., & Swetter, S. M. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0310 · Cited by 103
Self-citationNCCN Guidelines Insights: Melanoma, Version 3.2016
Coit, D. G., Thompson, J. A., Algazi, A. P., Andtbacka, R. H. I., Bichakjian, C. K., Carson, W. E., Daniels, G. A., DiMaio, D. J., Fields, R. C., Fleming, M. D., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0101 · Cited by 102
Self-citationLees, V. C., & Briggs, J. C. (1991) · British journal of surgery · doi:10.1002/bjs.1800780923 · Cited by 97
Uguen, A., Talagas, M., Costa, S., Duigou, S., Bouvier, S., Braekeleer, M. D., & Marcorelles, P. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0431-9 · Cited by 96
Stevenson, A. D., Mickan, S. M., Mallett, S., & Ayya, M. (2013) · Dermatology Practical & Conceptual · doi:10.5826/dpc.0304a05 · Cited by 94
Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck
Austin, J. R., Byers, R. M., Brown, W. D., & Wolf, P. (1996) · Head & Neck · doi:10.1002/(sici)1097-0347(199603/04)18:2 · Cited by 93
Melanoma underreporting: Why does it happen, how big is the problem, and how do we fix it?
Cockburn, M., Swetter, S. M., Peng, D., Keegan, T. H. M., Deapen, D., & Clarke, C. A. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.08.007 · Cited by 91
Self-citationHereditary melanoma: Update on syndromes and management
Soura, E., Eliades, P. J., Shannon, K., Stratigos, A., & Tsao, H. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.08.037 · Cited by 91
Self-citationUpdated Swiss guidelines for the treatment and follow-up of cutaneous melanoma
Dummer, R., Guggenheim, M., Arnold, A., Braun, R. P., & von Moos, R. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13320 · Cited by 87
Cutaneous Complications of Targeted Melanoma Therapy
de Golian, E., Kwong, B. Y., Swetter, S. M., & Pugliese, S. B. (2016) · Current Treatment Options in Oncology · doi:10.1007/s11864-016-0434-0 · Cited by 87
Self-citationTio, D., van der Woude, J., Prinsen, C. A. C., Jansma, E. P., Hoekzema, R., & van Montfrans, C. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14085 · Cited by 87
A nine-gene signature predicting clinical outcome in cutaneous melanoma
Brunner, G., Reitz, M., Heinecke, A., Lippold, A., Berking, C., Suter, L., & Atzpodien, J. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1322-z · Cited by 86
Pregnancy History and Incidence of Melanoma in Women: A Pooled Analysis
Karagas, M. R., Zens, M. S., Stukel, T. A., Swerdlow, A. J., Rosso, S., Østerlind, A., Mack, T. M., Kirkpatrick, C., Holly, E. A., Green, A. C., et al. (2006) · Cancer Causes & Control · doi:10.1007/s10552-005-0281-y · Cited by 83
Evaluating invasive cutaneous melanoma: Is the initial biopsy representative of the final depth?
Ng, P., BARZILAI, D. A., Ismail, S. A., et al. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.106 · Cited by 83
Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma
Weiss, S. A., Han, S. W., Lui, K. P., Tchack, J., Shapiro, R. L., Berman, R. S., Zhong, J., Krogsgaard, M., Osman, I., & Darvishian, F. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.07.008 · Cited by 83
Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma
Wang, T. S., Johnson, T. M., Cascade, P. N., Redman, B. G., Sondak, V. K., & Schwartz, J. L. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.017 · Cited by 81
Self-citationExcision Margins for Primary Cutaneous Melanoma
Lens, M. B. (2007) · Archives of Surgery · doi:10.1001/archsurg.142.9.885 · Cited by 81
Hsueh, E. C., DeBloom, J. R., Lee, J. W. J., Sussman, J. J., Covington, K. R., Middlebrook, B. S., Johnson, C. E., Cook, R. W., Slingluff, C. L., & McMasters, K. M. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0520-1 · Cited by 78
Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type
Swetter, S. M., Chen, F. W., Kim, D. D., & Egbert, B. M. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.02.008 · Cited by 77
Self-citationMalvehy, J., & Pellacani, G. (2017) · Acta Dermato Venereologica · doi:10.2340/00015555-2720 · Cited by 77
A systematic review of non‐surgical treatments for lentigo maligna
Read, T., Noonan, C., David, M., Wagels, M., Foote, M. C., Schaider, H., Soyer, H. P., & Smithers, B. M. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13252 · Cited by 76
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status
Ribero, S., Gualano, M. R., Osella‐Abate, S., Scaioli, G., Bert, F., Sanlorenzo, M., Balagna, E., Fierro, M. T., Macripò, G., Sapino, A., et al. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.2235 · Cited by 73
Champin, J., Perrot, J., Cinotti, É., Labeille, B., Douchet, C., Parrau, G., Cambazard, F., Séguin, P., & Alix, T. (2014) · Dermatologic Surgery · doi:10.1111/dsu.12432 · Cited by 73
Fong, Z. V., & Tanabe, K. K. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12687 · Cited by 73
Increased mortality for pregnancy‐associated melanoma: systematic review and meta‐analysis
Byrom, L., Olsen, C. M., Knight, L. L., Khosrotehrani, K., & Green, A. C. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12972 · Cited by 73
Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis
Schramm, S., Campain, A. E., Yang, J. Y. H., & Mann, G. J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.305 · Cited by 69
Lymphatic Invasion Is Independently Prognostic of Metastasis in Primary Cutaneous Melanoma
Xu, X., Chen, L., Guerry, D., Dawson, P., Hwang, W., VanBelle, P., Elder, D. E., Zhang, P. J., Ming, M. E., Schuchter, L. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0490 · Cited by 69
Self-citationTang, J. Y., Spaunhurst, K. M., Chlebowski, R. T., Wactawski‐Wende, J., Keiser, E., Thomas, F., Anderson, M. L., Zeitouni, N. C., Larson, J. C., & Stefanick, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr333 · Cited by 68
Tembe, V., Schramm, S., Stark, M. S., Patrick, E., Jayaswal, V., Tang, Y., Barbour, A. P., Hayward, N. K., Thompson, J. F., Scolyer, R. A., et al. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12343 · Cited by 66
Self-citationCancer in women after assisted reproductive technology
Luke, B., Brown, M. B., Spector, L. G., Missmer, S. A., Leach, R. E., Williams, M. A., Koch, L., Smith, Y. R., Stern, J. E., Ball, G. D., et al. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.07.1135 · Cited by 66
Moore, M. M., Geller, A. C., Warton, E. M., Schwalbe, J., & Asgari, M. M. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.06.059 · Cited by 64
Stigall, L. E., Brodland, D. G., & Zitelli, J. A. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.06.033 · Cited by 64
Hugdahl, E., Kalvenes, M. B., Mannelqvist, M., Ladstein, R. G., & Akslen, L. A. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.384 · Cited by 60
Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4
Fischer, A., Rosen, A. C., Ensslin, C. J., Wu, S., & Lacouture, M. E. (2013) · Dermatologic Therapy · doi:10.1111/dth.12027 · Cited by 55
Variability in melanoma post-treatment surveillance practices by country and physician specialty
Cromwell, K. D., Ross, M. I., Xing, Y., Gershenwald, J. E., Royal, R. E., Lucci, A., Lee, J. E., & Cormier, J. N. (2012) · Melanoma Research · doi:10.1097/cmr.0b013e328357d796 · Cited by 54
Self-citationGerami, P., Alsobrook, J. P., Palmer, T. J., & Robin, H. S. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.04.042 · Cited by 54
Accuracy of Diagnostic Biopsy for Cutaneous Melanoma: Implications for Surgical Oncologists
Hieken, T. J., Hernández-Irizarry, R., Boll, J. M., & Coleman, J. E. J. (2013) · International Journal of Surgical Oncology · doi:10.1155/2013/196493 · Cited by 54
Rueth, N. M., Xing, Y., Chiang, Y., Cromwell, K. D., Ross, M. I., Lee, J. E., Gershenwald, J. E., Royal, R. E., & Cormier, J. N. (2013) · Annals of Surgery · doi:10.1097/sla.0000000000000233 · Cited by 52
Self-citationGualano, M. R., Osella‐Abate, S., Scaioli, G., Marra, E., Bert, F., Faure, E., Baduel, E. S., Balagna, E., Quaglino, P., Fierro, M. T., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15552 · Cited by 52
Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis
Cordeiro, E., Gervais, M., Shah, P., Hong, N. L., & Wright, F. C. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5137-z · Cited by 51
Lyth, J., Hansson, J., Ingvar, C., Månsson‐Brahme, E., Naredi, P. L. J., Stierner, U. K., Wagenius, G., Lindholm, C., & for the Swedish Melanoma Study Group (2012) · British Journal of Dermatology · doi:10.1111/bjd.12095 · Cited by 50
Nsengimana, J., Laye, J. P., Filia, A., Walker, C., Jewell, R., van den Oord, J. J., Wolter, P., Patel, P. M., Sucker, A., Schadendorf, D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3549 · Cited by 49
Anforth, R. M., Carlos, G., Clements, A., Kefford, R. F., & Fernández‐Peñas, P. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13200 · Cited by 48
Newton‐Bishop, J., Nolan, C., Turner, F., McCabe, M., Barrett, J. H., Boxer, C., Thomas, J., Coombes, G., & A’Hern, R. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09118.x · Cited by 47
Digit-Sparing Mohs Surgery for Melanoma
Terushkin, V., Brodland, D. G., Sharon, D. J., & Zitelli, J. A. (2015) · Dermatologic Surgery · doi:10.1097/dss.0000000000000587 · Cited by 46
The incidence of second primary invasive melanoma in Queensland, 1982–2003
McCaul, K. A., Fritschi, L., Baade, P. D., & Coory, M. D. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9106-5 · Cited by 45
Aspinwall, L. G., Taber, J. M., Leaf, S. L., Kohlmann, W. K., & Leachman, S. A. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0422 · Cited by 43
Cartee, T. V., Kini, S. P., & Chen, S. C. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.05.032 · Cited by 42
Armour, K., Mann, S., & Lee, S. B. (2005) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2005.00144.x · Cited by 41
The prognostic importance of scalp location in primary head and neck melanoma
Ozao‐Choy, J. J., Nelson, D. W., Hiles, J. M., Stern, S. L., Yoon, J. L., Sim, M., & Faries, M. B. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24679 · Cited by 41
Follow‐Up Recommendations for Patients with Stage I Malignant Melanoma
ROMERO, J. B., Stefanato, C. M., Kopf, A. W., & Bart, R. S. (1994) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1994.tb00462.x · Cited by 40
Detection of Occult Invasion in Melanoma In Situ
Bax, M. J., Johnson, T. M., Harms, P. W., Schwartz, J. L., Zhao, L., Fullen, D. R., & Chan, M. P. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.2668 · Cited by 40
Self-citationNiebling, M. G., Haydu, L. E., Karim, R. Z., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3682-x · Cited by 37
Wain, R. A. J., & Tehrani, H. (2015) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2015.03.012 · Cited by 34
McKenna, D. B., Lee, R. J., Prescott, R. J., & Doherty, V. R. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05849.x · Cited by 33
Frauchiger, A. L., Mangana, J., Rechsteiner, M., Moch, H., Seifert, B., Braun, R. P., Dummer, R., & Goldinger, S. M. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14347 · Cited by 29
Variation in the Depth of Excision of Melanoma: A Survey of US Physicians
DeFazio, J., Marghoob, A. A., Pan, Y., Dusza, S. W., Khokhar, A., & Halpern, A. C. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.156 · Cited by 27
Self-citationHultgren, B. A., Turrisi, R., Mallett, K. A., Ackerman, S., & Robinson, J. K. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.2819 · Cited by 20
Mihic‐Probst, D., Shea, C. R., Duncan, L. M., de la Fouchardière, A., Landman, G., Landsberg, J., Oord, J., Lowe, L., Cook, M. G., Yun, S. J., et al. (2015) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000100 · Cited by 19
Self-citationAl-Rohil, R. N., Curry, J. L., Torres-Cabala, C. A., et al. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.02.019 · Cited by 14
Screening for Pancreatic Cancer in High-risk Populations
Grover, S., & Jajoo, K. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.10.001 · Cited by 13
Reporting Melanoma: A Nationwide Surveillance of State Cancer Registries
Raji, K., Payne, L. C., & Chen, S. C. (2015) · Journal of Skin Cancer · doi:10.1155/2015/904393 · Cited by 10
Harris, R. B., Koch, S. M., Newton, C., Silvis, N. G., Curiel‐Lewandrowski, C. N., Giancola, J. M., Sagerman, P. J., Alder, S., Yee, G., & Flood, T. J. (2015) · Public Health Reports · doi:10.1177/003335491513000624 · Cited by 10
Self-citation
Cited by
Long, G. V., Swetter, S. M., Menzies, A. M., Gershenwald, J. E., & Scolyer, R. A. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00821-8 · Cited by 746
Self-citationKassem, M. A., Hosny, K. M., & Fouad, M. M. (2020) · IEEE Access · doi:10.1109/access.2020.3003890 · Cited by 407
Swetter, S. M., Thompson, J. A., Albertini, M. R., Barker, C. A., Baumgartner, J., Boland, G., Chmielowski, B., DiMaio, D., Durham, A., Fields, R. C., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0018 · Cited by 340
Self-citationTumour gene expression signature in primary melanoma predicts long-term outcomes
Garg, M., Couturier, D.-L., Nsengimana, J., Fonseca, N. A., Wongchenko, M., Yan, Y., Lauss, M., Jönsson, G. B., Newton-Bishop, J., Parkinson, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21207-2 · Cited by 70
Self-citation
Metadata
- Authors
- Swetter, S. M., Tsao, H., Bichakjian, C. K., Curiel-Lewandrowski, C., Elder, D. E., Gershenwald, J. E., Guild, V., Grant-Kels, J. M., Halpern, A. C., Johnson, T. M., Sober, A. J., Thompson, J. A., Wisco, O. J., Wyatt, S., Hu, S., & Lamina, T.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 80
- Issue
- 1
- Pages
- 208-250
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W4253724883
- Cited by
- 727
- References
- 168
- FWCI
- 19.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.